Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at the beginning at Jun. 30, 2022 $ 2,882 $ 0 $ 152,454 $ (148,327) $ (1,245)
Balance at the beginning (In shares) at Jun. 30, 2022   480,688      
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs 16,015 $ 0 16,015    
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs, Shares   1,037,520      
Share-based compensation 302   302    
Foreign currency translation gain 507       507
Net loss (5,093)     (5,093)  
Balance at end at Sep. 30, 2022 14,613 $ 0 168,771 (153,420) (738)
Balance at end (In shares) at Sep. 30, 2022   1,518,208      
Balance at the beginning at Jun. 30, 2022 2,882 $ 0 152,454 (148,327) (1,245)
Balance at the beginning (In shares) at Jun. 30, 2022   480,688      
Foreign currency translation gain 347        
Net loss (10,504)        
Balance at end at Dec. 31, 2022 8,994 $ 0 168,720 (158,831) (898)
Balance at end (In shares) at Dec. 31, 2022   1,645,951      
Balance at the beginning at Sep. 30, 2022 14,613 $ 0 168,771 (153,420) (738)
Balance at the beginning (In shares) at Sep. 30, 2022   1,518,208      
Exercise of pre-funded warrants, Shares   127,743      
Share-based compensation (48)   (48)    
Foreign currency translation gain (160)       (160)
Net loss (5,411)     (5,411)  
Balance at end at Dec. 31, 2022 8,994 $ 0 168,720 (158,831) (898)
Balance at end (In shares) at Dec. 31, 2022   1,645,951      
Balance at the beginning at Jun. 30, 2023 202 $ 0 168,921 (167,889) (830)
Balance at the beginning (In shares) at Jun. 30, 2023   1,671,485      
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs 27,919 $ 0 27,919 0 0
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs, Shares   875,949      
Share-based compensation 91   91    
Foreign currency translation gain 50       50
Net loss (5,954)     (5,954)  
Balance at end at Sep. 30, 2023 22,308 $ 0 196,931 (173,843) (780)
Balance at end (In shares) at Sep. 30, 2023   2,547,434      
Balance at the beginning at Jun. 30, 2023 202 $ 0 168,921 (167,889) (830)
Balance at the beginning (In shares) at Jun. 30, 2023   1,671,485      
Foreign currency translation gain (122)        
Net loss (12,752)        
Balance at end at Dec. 31, 2023 15,470 $ 0 197,063 (180,641) (952)
Balance at end (In shares) at Dec. 31, 2023   2,592,434      
Balance at the beginning at Sep. 30, 2023 22,308 $ 0 196,931 (173,843) (780)
Balance at the beginning (In shares) at Sep. 30, 2023   2,547,434      
Exercise of pre-funded warrants, Shares   25,000      
Share-based compensation 93   93    
Foreign currency translation gain (172)       (172)
Net loss (6,798)     (6,798)  
Exercise of Series 2 warrants (In shares)   20,000      
Exercise of Series 2 warrants 39   39    
Balance at end at Dec. 31, 2023 $ 15,470 $ 0 $ 197,063 $ (180,641) $ (952)
Balance at end (In shares) at Dec. 31, 2023   2,592,434